Concepedia

Solid Dosage Form Analysis

Solid Dosage Form Analysis is a pharmaceutical analytical method that involves the systematic examination and characterization of solid medicinal formulations, distinguished by its focus on evaluating the physical, chemical, and functional properties of drugs in solid forms such as tablets, capsules, and powders to ensure identity, purity, potency, and quality.

158

Publications

5.4K

Citations

567

Authors

196

Institutions

Publications per year

2017–2026

30

Parents

Publications

158

Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy

Andrea Heinz, Clare J. Strachan, Keith C. Gordon et al. · Journal of Pharmacy and Pharmacology · 2009 · 212 citations

, , +17

Use of In-Line Near-Infrared Spectroscopy in Combination with Chemometrics for Improved Understanding of Pharmaceutical Processes

Jukka Rantanen, Håkan Wikström, Rebecca Turner et al. · Analytical Chemistry · 2004 · 154 citations

, , +17

Near-infrared chemical imaging (NIR-CI) on pharmaceutical solid dosage forms—Comparing common calibration approaches

Carsten Ravn, Erik Skibsted, Rasmus Bro · Journal of Pharmaceutical and Biomedical Analysis · 2008 · 150 citations

, , +16

Advantages of Artificial Neural Networks (ANNs) as alternative modelling technique for data sets showing non-linear relationships using data from a galenical study on a solid dosage form

Jacques Bourquin, Heinz Schmidli, Peter van Hoogevest et al. · European Journal of Pharmaceutical Sciences · 1998 · 141 citations

, , +11

Isocratic RP-HPLC method for rutin determination in solid oral dosage forms

Vesna Kuntić, Nataša Pejić, Branka Ivković et al. · Journal of Pharmaceutical and Biomedical Analysis · 2006 · 134 citations

, , +10

1–5 of 158

Authors

567

  1. BC
    Bruno C. Hancock

    Pfizer (United States), United States

    3 publications · 198 citations

    3

    h-index

  2. JR
    Jukka Rantanen

    University of Copenhagen, Denmark

    3 publications · 191 citations

    3

    h-index

  3. YR
    Yves Roggo

    Roche (Switzerland), Switzerland

    3 publications · 200 citations

    3

    h-index

  4. MW
    Marek Wesołowski

    Gdańsk Medical University, Poland

    3 publications · 72 citations

    3

    h-index

  5. ÇÇ
    Çetin Çetinkaya

    Clarkson University, United States

    2 publications · 63 citations

    2

    h-index

1–5 of 567

Institutions

196

  1. Pfizer (United States)

    New York, United States

    5 h-index

    7 publications

    438 citations

  2. Centre National de la Recherche Scientifique

    Paris, France

    4 h-index

    13 publications

    869 citations

  3. Merck & Co., Inc., Rahway, NJ, USA (United States)

    Rahway, United States

    4 h-index

    12 publications

    491 citations

  4. University of Minnesota

    Minneapolis, United States

    3 h-index

    5 publications

    143 citations

  5. Purdue University West Lafayette

    West Lafayette, United States

    3 h-index

    6 publications

    668 citations

  6. Dr. Reddy's Laboratories (United States)

    Princeton, United States

    3 h-index

    6 publications

    137 citations

  7. University of Otago

    Dunedin, New Zealand

    3 h-index

    11 publications

    1.1K citations

  8. Cairo University

    Giza, Egypt

    3 h-index

    6 publications

    117 citations

1–8 of 196

Venues

  1. 13

    h-index

  2. Journal of Pharmaceutical Sciences

    9 publications · 361 citations

    9

    h-index

  3. International Journal of Pharmaceutics

    8 publications · 377 citations

    8

    h-index

  4. Drug Development and Industrial Pharmacy

    7 publications · 168 citations

    7

    h-index

  5. Indian Journal of Pharmaceutical Sciences

    7 publications · 179 citations

    7

    h-index

1–5